7 Reasons Why PPD’s Acquisition will Help TMO Gain a Top Spot in the CRO Market
Frost & Sullivan
APRIL 21, 2021
Frost & Sullivan predicts the acquisition of PPD by Thermo Fisher Scientific (TMO) will boost TMO’s position to the top 3 in the C ontract Development and Manufacturing Organization ( CDMO) market. Here are 7 reasons why: 1 – While the earlier deals to acquire Patheon for $7.2 Bn and Brammer Bio for $1.7 Bn were focused on enhancing the manufacturing capabilities, PPD’s acquisition gives TMO an opportunity to tap in the preclinical discovery and clinical research outsourcing mark
Let's personalize your content